-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The 1,3-Dihydrothiopheno[3,2-d]pyrimidine-2,4-dione is a synthetic chemical compound that is commonly used in the chemical industry.
It is known for its unique properties and versatile applications.
However, safety concerns have been raised about this compound due to its potential toxicity and carcinogenicity.
In this article, we will discuss the safety of 1,3-Dihydrothiopheno[3,2-d]pyrimidine-2,4-dione in the chemical industry.
1,3-Dihydrothiopheno[3,2-d]pyrimidine-2,4-dione is a synthetic chemical compound that is commonly used in the chemical industry.
It is also known as 2,4-Dinitrophenylhydrazine or DNPH.
This compound is used as a reagent in various chemical reactions, such as in the synthesis of dyes, pigments, and pharmaceuticals.
It is also used in the production of polymers, cosmetics, and personal care products.
However, safety concerns have been raised about the use of 1,3-Dihydrothiopheno[3,2-d]pyrimidine-2,4-dione in the chemical industry.
Studies have shown that this compound has potential toxicity and carcinogenicity effects on human health.
Toxicity:
1,3-Dihydrothiopheno[3,2-d]pyrimidine-2,4-dione is known to be toxic to humans and animals.
It can cause skin irritation, respiratory problems, and allergic reactions.
Prolonged exposure to this compound can cause severe health problems, such as damage to the liver, kidneys, and central nervous system.
It can also cause cancer in humans and animals.
Carcinogenicity:
1,3-Dihydrothiopheno[3,2-d]pyrimidine-2,4-dione is classified as a probable human carcinogen by the International Agency for Research on Cancer (IARC).
Studies have shown that this compound can cause cancer in animals and is suspected of causing cancer in humans.
It can cause a variety of cancers, including cancers of the lung, liver, and bladder.
In addition to its toxicity and carcinogenicity, 1,3-Dihydrothiopheno[3,2-d]pyrimidine-2,4-dione is also mutagenic and teratogenic.
Mutagenicity refers to the ability of a compound to cause genetic mutations, while teratogenicity refers to the ability of a compound to cause birth defects.
These effects can be passed on to future generations, making 1,3-Dihydrothiopheno[3,2-d]pyrimidine-2,4-dione a potential threat to human health and the environment.
Risk Assessment:
To assess the risks associated with the use of 1,3-Dihydrothiopheno[3,2-d]pyrimidine-2,4-dione, it is important to consider the potential exposure levels of this compound.
Workers who handle this compound in the chemical industry are at the highest risk of exposure.
Therefore, it is important to take measures to protect their health and safety.
The risk assessment should also consider the environmental impact of 1,3-Dihydrothiopheno[3,2-d]pyrimidine-2,4-dione.
This compound can persist in the environment and bioaccumulate in living organisms, causing long-term damage to ecosystems and wildlife.
Control Measures:
To control the risks associated with the use of 1,3-Dihydrothi